How many insider declarations has Hawryluk P. Kent filed?

Hawryluk P. Kent has filed 5 public insider declarations with SEC (Form 4).

What is Hawryluk P. Kent's role?

Hawryluk P. Kent's reported role is not specified by the regulator across the filings.

Which companies does Hawryluk P. Kent report trades for?

Hawryluk P. Kent reports trades for MBX Biosciences, Inc..

What is Hawryluk P. Kent's declared buy vs sell volume?

Across the available history, declared buys total 1.2M€ and disposals 0.

← Executives ★ Sign in to follow

HP

Hawryluk P. Kent

CEO

·SEC (Form 4)

MBX Biosciences, Inc.

Cumul. flow

0

Total declarations

0

Company

€1m

▲ Purchases (3 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

3

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by Hawryluk P. Kent. Officer active across 1 company, notably MBX Biosciences, Inc.. Aggregated, 5 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €1.2m. Activity tracked since 4 February 2025. The latest transaction was disclosed on 13 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Hawryluk P. Kent

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

MBX Biosciences, Inc. (US)

Declarations5 total

▲

Hawryluk P. Kent

President & CEOExecutives13 Mar 2026MBX Biosciences, Inc.

$525,66331SEC ↗

18,500 shares@ US$28.414246.9% of flowCommon StockSEC:0001193125-26-107268:0

Canonical exit: 11 Jun 2026 (T+90)

◇

Hawryluk P. Kent

President & CEOExecutives24 Oct 2025MBX Biosciences, Inc.

$594,2920SEC ↗

182,859 shares@ US$3.25Common StockSEC:0001193125-25-252404:0

▲

Hawryluk P. Kent

President & CEOExecutives20 Oct 2025MBX Biosciences, Inc.

$272,7900SEC ↗

20,000 shares@ US$13.6395Common StockSEC:0001193125-25-245411:0

Canonical exit: 18 Jan 2026 (T+90)

▲

Hawryluk P. Kent

President & CEOExecutives4 Feb 2025MBX Biosciences, Inc.

$534,50049SEC ↗

50,000 shares@ US$10.69100.0% of flowCommon StockSEC:0000950170-25-014494:0

Canonical exit: 5 May 2025 (T+90)

●

Hawryluk P. Kent

President & CEOExecutives16 Sept 2024MBX Biosciences, Inc.

22SEC ↗

283,846 sharesCommon StockSEC:0000950170-24-107527:0

5 of 5 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

HP

Hawryluk P. Kent

CEO

·SEC (Form 4)

MBX Biosciences, Inc.

Cumul. flow

0

Total declarations

0

Company

€1m

▲ Purchases (3 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

3

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by Hawryluk P. Kent. Officer active across 1 company, notably MBX Biosciences, Inc.. Aggregated, 5 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €1.2m. Activity tracked since 4 February 2025. The latest transaction was disclosed on 13 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.